https://de.marketscreener.com/kurs/aktie/AMRYT-PHARMA-PLC-66481723/news/Amryt-erhalt-Marktzulassung-und-Orphan-Drug-Designation-fur-Filsuvez-R-in-Gro-britannien-41731748/?utm_source=telegram&utm_medium=social&utm_campaign=share